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Book Reviews
High Dose Rate Brachytherapy - A Textbook
Edited by Subir Nag. New York: Futura Publishing Co. Inc..
1994. 462 pp. 569.00.
Conventional brachytherapy has always been recognised as
an excellent way to deliver a high dose of radiation to the
heart of a tumour but has had the disadvantage that it takes
a long time and involves risk of radiation exposure. Recent
developments in afterloading technology and source design
now make it possible to give a high dose of radiation in a
verv short time without exposure hazard and with the pos-
sibility of optimising dose distribution. This multiauthor
book reviews recent experience in this rapidly growing field
and should be of interest to anyone who has just started or is
about to start high dose rate (HDR) brachytherapy.
Those who search for guidance on dose and fractionation
regimens are not going to find it. because with the exception
of a few sites there is too little experience and insufficient
follow-up on which to base advice.
HDR brachytherapy has an accepted role in the manage-
ment of carcinoma of the bronchus and oesophagus because
it allows rapid safe treatment that cannot readily be given in
any other way. It is also widely used in gynaecological
cancer. but for other sites there are still very few data. Manv
of the clinical chapters describe the individual techniques
used and the results of relatively few patients treated in
selected centres in the USA. They do. however. give useful
details on how to perform the implant. References are plen-
tiful and up to date with many after 1990. but there is little
attempt to place HDR brachytherapy within the context of
other treatments. and many valuable European data have not
been included. The strongest sections are on the new
dosimetry methods that have become available and their
integration with imaging and with dose optimisation. There
is also a very full discussion of the potentially serious issue of
quality assurance.
Most of the criticisms are because the subject is so new
that many of the questions arising from it have yet to be
answered. It is perhaps too soon for a definitive textbook but
the data presented give a good view of the current position.
even though much may change over the next few years.
DV Ash
Fssential OncologM for Health Professionals
EML Haagedoorn. J Oldhoff. W Bender. WD Clarke and
DTh Sleijfer. Van Gorcum: Assen. 1994. 408 pp. Dfl 85.00.
ISBN 902 3229053
This book presents the principles of clinical oncology aimed
at the multidisciplinary teams that are now invariably
involved in cancer care. Details of chemotherapy are not
provided. although side-effects from chemotherapy and
radiotherapy provide a significant morbidity for the
oncologist and generalist. There is a definitive description of
TNM staging. but prognosis is not fully discussed according
to specific subgroups of patients which is important in. for
example, breast cancer. The level is realistically medical
undergraduate rather than postgraduate apart from pro-
viding a very general overview. There is a lack of essential
biological and pathological detail in most chapters. and often
important predisposing factors for cancer development are
summarised too generally. for example as 'genetic' or
environrmental events'. Notable bv their absence are con-
siderations of cancer genetics and genetic counselling.
oncogenes and cytogenetic studies. which accentuates the
old-fashioned feel of the book. The role of tumour markers is
oversimplified. particularly in the management of germ cell
tumours. where much more detail is essential as salvage
treatment may be instituted solely on a raised marker result.
It is a concern that a chapter on cancer and nutrition makes
no mention of temporary total parenteral nutrition (TPN)
and enteral feeding with PEG (percutaneous endoscopic gast-
rostomy) which have had a profound effect on patient man-
agement in the last few years. The patient problems' section
is a little confusing: rather than re-examining general app-
roaches to diagnosis and investigation often 'spot diagnoses'
are mentioned and referral to specialists advised rather than
working through logical management strategies. A glossary
of terms and references for further reading would have been
useful for the non-specialist. 'Learning points' boxes would
allow quicker reference and improve the look of the book as
would more imaginative (and preferably colour) illustrations.
In summary. it is difficult to identif) a target readership for
this book, particularly with competing publications being
more modern in approach and presentation.
Hardev Pandha MRCP
Nick Lemoine MD PhD MRCPath
Endocrine Tumours
Ernest L Mazzafern and Nagib A Samaan. Blackwell
Science: Oxford. 1995. 86pp. £150.00. ISBN 0 865422672
This book certainly fills a gap as endocrine oncology has
tended to be considered as a Cinderella subject in the
oncology field. although past oncologists who have looked
after thyroid and endocrine cancer have included some most
distinguished individuals. This is generally a most excellent
and comprehensive book which covers best the expected
areas. However. I did wonder whether it was really necessary
to try and be all-embracing and include sections on prostate
cancer. testis cancer. germ cell cancers and breast tumours.
These chapters are really only superficially covered and might
better have been omitted altogether and left to a general
oncology textbook or a specialist book. Nevertheless, the
overall impression is of an excellent reference book.
I have not attempted to review the entire book since it is
some 800-odd pages in length and there are several areas that
do not come into my clinical practice. such as pituitary
tumours. I have therefore concentrated on the thyroid.
adrenal. pancreatic and gastrointestinal endocrine cancers
and the carcinoid tumours, which constitute at least two-
thirds of the content of the book.
Thyroid cancer management presents a well-balanced over-
view. putting forward both sides of the arguments in those
areas where there are many and deep controversies. Occas-
sionally the authors' individual prejudices are allowed to
shine through, but nevertheless the balance is generally very
well done. There are plenty of good illustrations. tables and
graphs which are clear and easy to understand. The section is
well referenced and very comprehensive.
Adrenal neoplasms are also covered in depth: particularly
well covered is the area on the work-up and diagnosis of
adrenal neoplasms. although the non-surgical management is
rather poorer. and the coverage of treatment with radionuc-
lides such as ['3I]MIBG and chemotherapy is almost dismis-
sive. It is perhaps unfortunate that an oncologist did not
contribute to this chapter. Furthermore. there is no mention
of the use of indium-labelled octreotide in the diagnostic
section of neuroendocrine tumours. which may represent an
American bias.
Again the section on the gastrointestinal and pancreatic
neuroendocrine cancers is generally well done. although it isBoo Po
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curious that over 30 pages are allocated to insulinomas and
virtually the same to all the other gastrointestinal and panc-
reatic endocnne tumours.
As I have already hinted, the only major omission that I
can find is the limited reference to the use of octreoscan as a
diagnostic agent, which in Europe has become an essential
part of the modern diagnostic protocol for the investigation
of neuroendocrine cancers. However, this can clearly be
updated in future editions, as I am sure this will reach a
second edition. Furthermore, in a future edition a little more
emphasis could be included on the non-surgical therapies of
these cancers.
Who is going to buy this book? Reference libraries should
consider this a must, and it will certainly be purchased by
oncologists, endocrinologists and surgical oncologists with an
interest in thyroid and endocrine cancers. However, the
general oncologist is probably not going to have this on his
shelf. It is also unfortunate that within the next year there is
going to be a rival European book published which is likely
to cover the same ground. However, it may well be that the
volumes are complementary rather than directly rivalling
each other.
In conclusion, this is an excellent book which plugs a gap
that needed filling. It is a must for the reference library and a




Edited by AC Minson, JC Neil and MA McCrae, Camb-
ridge: Cambridge University Press, 1994, 309 pp. £55. ISBN
0-52145472-7.
The story of viruses and cancer is important for two distinct
reasons. First, some 15% or more of human cancer incidence
is linked with virus infection. Major malignancies in the
world, such as cancer of the uterine cervix, primary liver
cancer, nasopharyngeal carcinoma (NPC) and several forms
of adult T-cell leukaemias and lymphomas, have viruses as
an essential component of their aetiology and pathogenesis.
Second, oncogenic viruses opened up cancer genetics.
Oncogenes were first found in retroviruses long bef6re it was
realised that the viruses had purloined cellular genes.
Tumour-suppressor proteins were first identified through the
study of DNA viruses, as viral proteins such as E6 and E7 of
the human papillomaviruses sequester the Rb and p53 pro-
teins, which is the phenotypic equivalent of a genetic knock-
out. Thus, studies of oncogenic viruses have had a
significance far beyond that proportion of cancer actually
caused by them.
This volume on viruses and cancer represents papers given
at the 51st Symposium of the British Society for General
Microbiology. It provides a useful overview of current
research into oncogenic viruses. While some chapters are
broad reviews, others are focused more narrowly on the
authors' own research.
I particularly enjoyed David Lane's chapter on tumour-
suppressor genes and p53 and Karen Vousden's article on
cell transformation by human papillomaviruses. More than
50 pages in the volume are devoted to Epsten-Barr virus
(EBV) in relation to B-cell transformation and tumours,
whereas only two pages discuss NPC. This is in inverse ratio
to the prevalee of these tumours, and reveals the inclina-
tions of EBV specialists: lymphomas are easier to study than
carcinomas. Human adenoviruses, perhaps the most potent
oncogenc viruses of all when experimentally inoculated into
rodents, receive no mention at all, not even in George Klein's
introductory article. Perhaps they are deemed uninteresting
because they have not been associated with human cancer,
and not for want of trying. Yet this very negation is fas-
cinating and puzzling.
In the majority of well-studied viral cancers, the viral
genome plays a direct role in cell transformation and the
maintenance of the malignant phenotype. Integrated or
episomal viral genes are found in the tumour cell clones.
However, it is also becoming increasingly evident that viruses
can predispose to cancer indirectly. In this volume Ian Weller
illustrates HIV-related cancers with respect to immune
deficiency, while Jan Butel and colleagues discuss hver cancer
is relation to hepatitis B and C viruses, where chronic liver
damage may promote the emergence of the premalignant
clones of liver cells not infected by the virus.
Viral carcinogenesis may be direct or indirect, but in both
cases it can be prevented by immunisation against viral infec-
tion in the first place. Here, vaccination is discussed only in
relation to human and bovine papillomaviruses and feline
leukaemia virus. However, successful intervention studies
against hepatitis B virus are already under way in West
Africa, and time will tell if this leads to a significant drop in
the incidence of liver cancer. There appears to be a synergis-
tic relationship between virus and dietary carcinogens briefly
mentioned by Butel et al. for liver cancer and by Saveria
Campo for bovine papillomavirus type 4. A more thorough
discussion of co-factors in viral oncogenesis and the pro-
spects for prevention would not have come amiss. Nonethe-
less, for those intrested in the relation of viruses to cancer,
this volume provides a useful introduction to the field.
Professor RA Weiss
Haematologiel Ocolgy - Cambridge Medical Reviews
Vo_=e 3
Edited by A Burnett, J Armitage, A Newland and A
Keating, Cambridge: Cambridge University Press, 1994, £50
hardback. ISBN: 0 521 44208 7.
This is the third volume in the series of reviews highlighting
growth areas in haematological oncology aimed at both
clinicians and research workers. The editors set themselves a
very difficult task in accepting such a wide remit and by and
large achieve a lot. However, such review texts become rather
piecemeal and lack the continuity of a monograph or text
committed to a specific topic. Consequently, in this volume
there is something for everyone but no topic is fully covered,
e.g. the epidemiology and viral aetiology of lymphomas are
included, but these are not put into the context of clinical
manifestation, immunophenotyping or pathology. For the
clinician reviewing a topic or for the hard-pressed examina-
tion candidate multiple texts are thus required, while the
researcher is more likely to find value in the bibliographies
and hence the original papers.
Those critical comments are applicable to all such texts
and must not detract from the well-written individual cont-
ributions, all by respected authorities in their field. Cart-
wright and McNally's Epidemiology ofNon-Hodgkin's Lym-
phomas is an excellent reference source, although so many
large tables make it difficult for the reader. I was confused by
the comment that 'no clear geographical associations
emerged' in childhood NHL and then the discussion of Bur-
kitt's lymphoma, for which there is a very characteristic
geographical variation. There were many other intriguing
items of interest which, as the authors suggest, do really
warrant further research. Onions has produced a very fine
and comprehensive overview of the viral aetiology of lym-
phoid malignancies, as has Myrtle Gordon on the stromal
microenvironment. The stroma is a complex area to study
but represents a real growing point of haematological
research, and this is a timely review of the subject. The
back-to-back chapters on myeloma therapy are especially
helpful to the practitioner deciding on therapy for an individ-
ual patient, and in particular Diana Sampson's final recom-
mendations are clear and very useful. Peripheral blood stem
cell transplantation is very much the flavour of the month,
for obvious reasons, but with the available growth factors
changing so rapidly texts such as this one inevitably become